Delivery Order SPE2DB22D2103-SPE2DB24FR9JW

Award Date 5/20/24
Potential Completion Date 5/21/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,763.24 firm-fixed-price delivery order is for the supply of Vimpat 100 mg tablets, a medication used to treat epilepsy. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,161.28 firm fixed-price delivery order is for the supply of Vimpat 100 mg tablets, a medication used to treat epilepsy. The contract has an ultimate completion date of September 21, 2022 and was awarded on September 20, 2022. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award, valued at $14,388.12, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Vimpat 100 mg tablets, a prescription medication used to treat seizures. The award is a delivery order issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp's parent company, Cencora, Inc., and the DLA Troop Support Medical. This $999,999,999 IDC serves as...
This federal contract award is a delivery order valued at $1,244.53, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Vimpat 100 mg tablets, a medication used to treat epilepsy. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that specializes in...
This federal contract award, valued at $2,980.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of Vimpat 100 mg tablets, a prescription medication used to treat epilepsy. This award...
This federal contract award is for the delivery of Vimpat 50 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,211.76, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the supply of Vimpat 200 mg tablets, a prescription medication used to treat epilepsy, to support military healthcare programs globally. The delivery order has a ceiling value of $2,310.42 and a completion date of December 10, 2024. The contract is a firm fixed-price,...
This federal contract award, valued at $3,311.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Vimpat 100 mg tablets and has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award, with a ceiling value of $1,021.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of Vimpat 200 mg tablets, a medication used for the treatment of epilepsy. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary...
This federal contract award, valued at $3,683.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Vimpat 10 mg/ml solution, a specialty medication used for the treatment of partial-onset seizures. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB24FR9JW
    Delivery Order

This federal contract award, valued at $7,209.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vimpat 100 mg tablets, a specialty medication used for the treatment of certain types of epilepsy.

The contract is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/16/25, 12:14 PM